Complement anaphylatoxin C4a inhibits C5a-induced neointima formation following arterial injury

Molecular Medicine Reports

Volumn 10, Issue 1, 2014, Pages 45-52

  Zhao, Yan ^a   Xu, Heng ^b   Yu, Wenhui ^c   Xie, Bao Dong ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b HEILONGJIANG PROVINCIAL HOSPITAL   (China)

^c HEILONGJIANG UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Atherosclerosis; Complement anaphylatoxin C4a; Complement anaphylatoxin C5a; Macrophage; Neointima formation

Indexed keywords

CD68 ANTIGEN; COMPLEMENT COMPONENT C4A; COMPLEMENT COMPONENT C5A; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; CALCIUM; CHEMOKINE; CYTOKINE; RECOMBINANT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTERY INJURY; ARTICLE; CALCIUM TRANSPORT; CELL MIGRATION; CELL PROLIFERATION; FEMORAL ARTERY; HEPG2 CELL LINE; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NEOINTIMA; NONHUMAN; PERITONEUM MACROPHAGE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; UPREGULATION; VASCULAR SMOOTH MUSCLE; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; GENETICS; MACROPHAGE; METABOLISM; PATHOLOGY; SMOOTH MUSCLE FIBER;

ANIMALS; CALCIUM; CELLS, CULTURED; CHEMOKINES; COMPLEMENT C4A; COMPLEMENT C5A; CYTOKINES; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMORAL ARTERY; MACROPHAGES; MICE; MICE, INBRED C57BL; MYOCYTES, SMOOTH MUSCLE; NEOINTIMA; RECOMBINANT PROTEINS; VASCULAR CELL ADHESION MOLECULE-1;

EID: 84901397162     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.2176     Document Type: Article

References (39)

1. Ivanov V, Cha J, Ivanova S, Kalinovsky T, Rath M and Niedzwiecki A: Nutrient supplementation modulates angiotensin II-mediated atherosclerosis in ApoE KO mice. Mol Med Rep 3: 417-425, 2010.
2. Packard RR, Lichtman AH and Libby P: Innate and adaptive immunity in atherosclerosis. Semin Immunopathol 31: 5-22, 2009.
3. Mayr M and Xu Q: Smooth muscle cell apoptosis in arteriosclerosis. Exp Gerontol 36: 969-987, 2001. (Pubitemid 32515215)
4. Dzau VJ, Braun-Dullaeus RC and Sedding DG: Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies. Nat Med 8: 1249-1256, 2002. (Pubitemid 35373556)
5. Newby AC and Zaltsman AB: Molecular mechanisms in intimal hyperplasia. J Pathol 190: 300-309, 2000. (Pubitemid 30141376)
6. Stone JD, Narine A, Shaver PR, Fox JC, Vuncannon JR and Tulis DA: AMP-activated protein kinase inhibits vascular smooth muscle cell proliferation and migration and vascular remodeling following injury. Am J Physiol Heart Circ Physiol 304: H369-H381, 2013.
7. Korshunov VA and Berk BC: Smooth muscle apoptosis and vascular remodeling. Curr Opin Hematol 15: 250-254, 2008. (Pubitemid 351507578)
8. Sata M, Maejima Y, Adachi F, Fukino K, Saiura A, Sugiura S, Aoyagi T, Imai Y, Kurihara H, Kimura K, Omata M, Makuuchi M, Hirata Y and Nagai R: A mouse model of vascular injury that induces rapid onset of medial cell apoptosis followed by reproducible neointimal hyperplasia. J Mol Cell Cardiol 32: 2097-2104, 2000.
9. Niculescu F and Rus H: The role of complement activation in atherosclerosis. Immunol Res 30: 73-80, 2004. (Pubitemid 38998650)
10. Shagdarsuren E, Bidzhekov K, Djalali-Talab Y, Liehn EA, Hristov M, Matthijsen RA, Buurman WA, Zernecke A and Weber C: C1-esterase inhibitor protects against neointima formation after arterial injury in atherosclerosis-prone mice. Circulation 117: 70-78, 2008. (Pubitemid 350291183)
11. Shagdarsuren E, Bidzhekov K, Mause SF, Simsekyilmaz S, Polakowski T, Hawlisch H, Gessner JE, Zernecke A and Weber C: C5a receptor targeting in neointima formation after arterial injury in atherosclerosis-prone mice. Circulation 122: 1026-1036, 2010.
12. Pushparaj PN, Tay HK, Wang CC, Hong W and Melendez AJ: VAMP8 is essential in anaphylatoxin-induced degranulation, TNF-alpha secretion, peritonitis, and systemic inflammation. J Immunol 183: 1413-1418, 2009.
13. Rectenwald JE, Moldawer LL, Huber TS, Seeger JM and Ozaki CK: Direct evidence for cytokine involvement in neointimal hyperplasia. Circulation 102: 1697-1702, 2000.
14. Tsuruta T, Yamamoto T, Matsubara S, Nagasawa S, Tanase S, Tanaka J, Takagi K and Kambara T: Novel function of C4a anaphylatoxin. Release from monocytes of protein which inhibits monocyte chemotaxis. Am J Pathol 142: 1848-1857, 1993.
15. Murakami Y, Yamamoto T, Imamichi T and Nagasawa S: Cellular responses of guinea pig macrophages to C4a; inhibition of C3a-induced O2-generation by C4a. Immunol Lett 36: 301-304, 1993. (Pubitemid 23214538)
16. Takaoka M, Nagata D, Kihara S, Shimomura I, Kimura Y, Tabata Y, Saito Y, Nagai R and Sata M: Periadventitial adipose tissue plays a critical role in vascular remodeling. Circ Res 105: 906-911, 2009.
17. Miyata K, Oike Y, Hoshii T, Maekawa H, Ogawa H, Suda T, Araki K and Yamamura K: Increase of smooth muscle cell migration and of intimal hyperplasia in mice lacking the alpha/beta hydrolase domain containing 2 gene. Biochem Biophys Res Commun 329: 296-304, 2005. (Pubitemid 40255453)
18. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685, 1970.
19. Kyhse-Andersen J: Electroblotting of multiple gels: a simple apparatus without buffer tank for rapid transfer of proteins from polyacrylamide to nitrocellulose. J Biochem Biophys Methods 10: 203-209, 1984.
20. Falk W, Goodwin RH Jr and Leonard EJ: A 48-well micro chemotaxis assembly for rapid and accurate measurement of leukocyte migration. J Immunol Methods 33: 239-247, 1980.
21. Nishiura H, Tokita K, Li Y, Harada K, Woodruff TM, Taylor SM, Nsiama TK, Nishino N and Yamamoto T: The role of the ribosomal protein S19 C-terminus in Gi protein-dependent alternative activation of p38 MAP kinase via the C5a receptor in HMC-1 cells. Apoptosis 15: 966-981, 2010.
22. Doran AC, Meller N and McNamara CA: Role of smooth muscle cells in the initiation and early progression of atherosclerosis. Arterioscler Thromb Vasc Biol 28: 812-819, 2008. (Pubitemid 351544093)
23. Hugli TE: Biochemistry and biology of anaphylatoxins. Complement 3: 111-127, 1986.
24. Manthey HD, Woodruff TM, Taylor SM and Monk PN: Complement component 5a (C5a). Int J Biochem Cell Biol 41: 2114-2117, 2009.
25. Naik N, Giannini E, Brouchon L and Boulay F: Internalization and recycling of the C5a anaphylatoxin receptor: evidence that the agonist-mediated internalization is modulated by phosphorylation of the C-terminal domain. J Cell Sci 110: 2381-2390, 1997. (Pubitemid 127699153)
26. Matsubara S, Yamamoto T, Tsuruta T, Takagi K and Kambara T: Complement C4-derived monocyte-directed chemotaxis inhibitory factor. A molecular mechanism to cause polymorphonuclear leukocyte-predominant infiltration in rheumatoid arthritis synovial cavities. Am J Pathol 138: 1279-1291, 1991.
27. Rua-Figueroa I, Arencibia-Mireles O, Elvira M, Erausquin C, Ojeda S, Francisco F, Naranjo A, Rodriguez-Gallego C, Garcia-Laorden I, Rodríguez-Perez J and Rodríguez-Lozano C: Factors involved in the progress of preclinical atherosclerosis associated with systemic lupus erythematosus: a 2-year longitudinal study. Ann Rheum Dis 69: 1136-1139, 2010.
28. Monk PN, Scola AM, Madala P and Fairlie DP: Function, structure and therapeutic potential of complement C5a receptors. Br J Pharmacol 152: 429-448, 2007. (Pubitemid 47585036)
29. Weaver DJ Jr, Reis ES, Pandey MK, Köhl G, Harris N, Gerard C and Köhl J: C5a receptor-deficient dendritic cells promote induction of Treg and Th17 cells. Eur J Immunol 40: 710-721, 2010.
30. Braun M, Pietsch P, Schrör K, Baumann G and Felix SB: Cellular adhesion molecules on vascular smooth muscle cells. Cardiovasc Res 41: 395-401, 1999. (Pubitemid 29087336)
31. Shagdarsuren E, Djalali-Talab Y, Aurrand-Lions M, Bidzhekov K, Liehn EA, Imhof BA, Weber C and Zernecke A: Importance of junctional adhesion molecule-C for neointimal hyperplasia and monocyte recruitment in atherosclerosis-prone mice-brief report. Arterioscler Thromb Vasc Biol 29: 1161-1163, 2009.
32. Jones SA: Directing transition from innate to acquired immunity: defining a role for IL-6. J Immunol 175: 3463-3468, 2005.
33. Tanaka J, Tajima S, Asakawa K, Sakagami T, Moriyama H, Takada T, Suzuki E and Narita I: Preventive effect of irbesartan on bleomycin-induced lung injury in mice. Respir Investig 51: 76-83, 2013.
34. Lee GL, Chang YW, Wu JY, Wu ML, Wu KK, Yet SF and Kuo CC: TLR 2 induces vascular smooth muscle cell migration through cAMP response element-binding protein-mediated interleukin-6 production. Arterioscler Thromb Vasc Biol 32: 2751-2760, 2012.
35. Xing J, Peng K, Cao W, Lian X, Wang Q and Wang X: Effects of total flavonoids from Dracocephalum moldavica on the proliferation, migration, and adhesion molecule expression of rat vascular smooth muscle cells induced by TNF-α. Pharm Biol 51: 74-83, 2013.
36. 2+ influx in neutrophils via a pertussis-toxin-sensitive G protein. Eur J Biochem 217: 289-294, 1993.
37. Zhou W: The new face of anaphylatoxins in immune regulation. Immunobiology 217: 225-234, 2012.
38. 2+-and protein kinase C-dependent signaling pathway for nuclear factor-kappaB activation, inducible nitric-oxide synthase expression, and tumor necrosis factor-alpha production in lipopolysaccharide-stimulated rat peritoneal macrophages. J Biol Chem 281: 31337-31347, 2006.
39. 2+ influx by surfactant in NR8383 alveolar macrophages. Inflamm Res 57: 489-496, 2008.